K2M Enters the Biomaterials Sector of the Spinal Market
LEESBURG, VA … October 14, 2008 – K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced that it has entered the next generation of materials technology in the spine market. Biomaterials is a rapidly expanding sector of the spinal industry that uses polymers and biological materials for bone grafting instead of the metals commonly used for spinal fusions. Biological materials allow for increased cellular activity, growth and differentiation which may increase bone formation and stimulate a spinal fusion.
John Schmidt, PhD joined K2M as Director of Biomaterials Technology to help lead the company’s efforts during this new era. He has an extensive background working with high risk, Class III, medical devices using polymers and biologics. Dr. Schmidt formerly served as a Technical Expert for the British Standards Institute (BSI America), the Director of Engineering for Quetzal Biomedical, as well as Staff Scientist and Project Leader for Intermedics in their Pacemaker Division. He holds a PhD in Bioengineering from Clemson University.
“K2M is excited to be a part of this exciting new era of biomaterials in the spine industry that offers so much hope for patients because it has the potential to dramatically improve the outcome of spine surgeries,” stated Eric Major, K2M’s president and CEO. “We are extremely pleased to have John Schmidt on board to help us develop this sector, which looks to have a promising future in the spine market.”
K2M, Inc. is an innovative spinal device company that develops simplified solutions for the treatment of complex spinal pathologies and procedures. Chief Medical Officer, Chairman and co-founder, Dr. John Kostuik, former Chief of Spine Surgery at The Johns Hopkins University School of Medicine, drives K2M’s commitment to redefining the market. K2M’s comprehensive line of products include: stabilization systems, minimally invasive systems, and other advancements in spine solutions for Degenerative Disc Disease (DDD), as well as deformity, trauma, and tumor. Additional information is available online at www.K2M.com.